Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine

NCT05460377 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT05460377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05460377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine
Lead sponsor
Centers for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
July 26, 2022
Completion date
December 1, 2024
Enrollment
1,224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis